1. Volume 84, Issue 4, Pages 810-817 (October 2013)
Serum β2-microglobulin at discharge predicts mortality and graft loss following kidney transplantation 
Brad C. Astor, Brenda Muth, Dixon B. Kaufman, John D. Pirsch, R. Michael Hofmann, Arjang Djamali 
Kidney International 
Volume 84, Issue 4, Pages (October 2013)
DOI: /ki
Copyright © 2013 International Society of Nephrology Terms and Conditions

2. Figure 1
Correlation of serum β2-microglobulin and serum creatinine. Both axes are logarithmic scale.
Kidney International  , DOI: ( /ki )
Copyright © 2013 International Society of Nephrology Terms and Conditions

3. Figure 2
Kaplan–Meier survival curves, by β2-microglobulin (β2M) quintile. Outcomes are (a) death, (b) death-censored graft loss, and (c) total graft loss.
Kidney International  , DOI: ( /ki )
Copyright © 2013 International Society of Nephrology Terms and Conditions

4. Figure 3
Adjusted incidence rate, by serum β2-microglobulin. Outcomes are (a) death, (b) death-censored graft loss, and (c) total graft loss. Adjusted incidence rate (darker line) and 95% confidence intervals (shaded area) were estimated from Poisson models adjusted to the mean values for age, sex, race, history of diabetes, history of cardiovascular disease, body mass index, pretransplant dialysis, sensitization, donor status, donor age, induction agents, presence of delayed graft function, length of hospitalization, immunosuppression agents, and estimated glomerular filtration rate category at discharge.
Kidney International  , DOI: ( /ki )
Copyright © 2013 International Society of Nephrology Terms and Conditions